THE ANTIBODY-DRUG CONJUGATE ABT-414 DEMONSTRATES SINGLE-AGENT ANTI-CANCER ACTIVITY ACROSS A PANEL OF GBM PATIENT-DERIVED XENOGRAFTS

被引：0
|
作者：
Marin, Bianca [1 ]
Mladek, Ann [2 ]
Burgenske, Danielle [2 ]
He, Lihong [1 ]
Hu, Zeng [2 ]
Bakken, Katrina [2 ]
Carlson, Brett [2 ]
Schroeder, Mark [2 ]
Sarkaria, Jann [3 ]
机构：
[1] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA
[2] Mayo Clin, Rochester, MN USA
[3] Mayo Clin, Translat Neurooncol Lab, Rochester, MN USA
来源：
NEURO-ONCOLOGY | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DDIS-01
引用
收藏
页码：69 / 69
页数：1
相关论文
共 37 条
  • [1] Preclinical Antitumor Activity and Biodistribution of a Novel Anti-GCC Antibody-Drug Conjugate in Patient-derived Xenografts
    Abu-Yousif, Adnan O.
    Cvet, Donna
    Gallery, Melissa
    Bannerman, Bret M.
    Ganno, Michelle L.
    Smith, Michael D.
    Lai, Katharine C.
    Keating, Thomas A.
    Stringer, Bradley
    Kamali, Afrand
    Eng, Kurt
    Koseoglu, Secil
    Zhu, Andy
    Xia, Cindy Q.
    Landen, Melissa Saylor
    Borland, Maria
    Robertson, Robbie
    Bolleddula, Jayaprakasam
    Qian, Mark G.
    Fretland, Jennifer
    Veiby, O. Petter
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (10) : 2079 - 2088
  • [2] ABT-414: An anti-EGFR antibody-drug conjugate as a potential therapeutic for the treatment of patients with squamous cell tumors
    Phillips, Andrew G.
    Boghaert, Erwin R.
    Vaidya, Kedar S.
    Ansell, Peter J.
    Shalinsky, David R.
    Zhang, Yumin
    Voorbach, Martin J.
    Mudd, Sarah
    Nolen, Kyle D.
    Humerickhouse, Rod A.
    Reilly, Edward B.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [3] Efficacy of a novel antibody-drug conjugate (ADC), ABT-414, as monotherapy in epidermal growth factor receptor (EGFR) amplified, recurrent glioblastoma (GBM).
    Van den Bentt, Martin J.
    Gan, Hui Kong
    Lassman, Andrew B.
    Kumthekar, Priya
    Merrell, Ryan
    Butowski, Nicholas A.
    Lwin, Zarnie
    Mikkelsen, Tom
    Nabors, Louis B.
    Papadopoulos, Kyriakos P.
    Penas-Prado, Marta
    Simes, John
    Wheeler, Helen
    Gomez, Erica J.
    Lee, Ho-Jin
    Roberts-Rapp, Lisa
    Xiong, Hao
    Bain, Earle E.
    Holen, Kyle D.
    Reardon, David A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] EFFICACY OF A NOVEL ANTIBODY-DRUG CONJUGATE (ADC), ABT-414, AS MONOTHERAPY IN EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFIED, RECURRENT GLIOBLASTOMA (GBM)
    van den Bent, M.
    Gan, H. K.
    Lassman, A. B.
    Kumthekar, P.
    Butowski, N.
    Lwin, Z.
    Nabors, L. B.
    Simes, J.
    Holen, K.
    Reardon, D. A.
    NEURO-ONCOLOGY, 2016, 18 : 44 - 44
  • [5] Efficacy Studies of an Antibody-Drug Conjugate PSMA-ADC in Patient-Derived Prostate Cancer Xenografts
    DiPippo, Vincent A.
    Olson, William C.
    Nguyen, Holly M.
    Brown, Lisha G.
    Vessella, Robert L.
    Corey, Eva
    PROSTATE, 2015, 75 (03): : 303 - 313
  • [6] The novel tubulin-binding 'tumor checkpoint controller' BAL101553 has anti-cancer activity alone and in combination treatments across a panel of GBM patient-derived xenografts
    Mladek, Ann C.
    Pokorny, Jenny L.
    Lane, Heidi
    Bachmann, Felix
    Schroeder, Mark A.
    Bakken, Katrina K.
    Carlson, Brett L.
    Decker, Paul A.
    Eckel-Passow, Jeanette E.
    Sarkaria, Jann N.
    CANCER RESEARCH, 2016, 76
  • [7] The antibody-drug conjugate D3-GPC2-PBD potently eradicates neuroblastoma patient-derived xenografts
    Bosse, Kristopher R.
    Zhu, Zhongyu
    Lane, Maria
    Martinez, Daniel
    DeLong, John
    Zhelev, Doncho V.
    Feng, Yang
    Wang, Yanping
    Hwang, Jennifer
    Dimitrov, Dimiter S.
    Maris, John
    CANCER RESEARCH, 2018, 78 (13)
  • [8] ATG-022, an antibody-drug conjugate targeting Claudin 18.2, demonstrated potent in vivo efficacy in gastric cancer patient-derived xenografts
    Chen, Peng
    Liu, Yun
    Deng, Min
    Tian, Linjie
    Lynch, Kevin
    Shan, Bo
    Mei, Jay
    Hou, Bing
    CANCER RESEARCH, 2022, 82 (12)
  • [9] Autologous humanized mouse models to study combination and single-agent immunotherapy for colorectal cancer patient-derived xenografts
    Kanikarla Marie, Preeti
    Sorokin, Alexey V.
    Bitner, Lea A.
    Aden, Rebecca
    Lam, Michael
    Manyam, Ganiraju
    Woods, Melanie N.
    Anderson, Amanda
    Capasso, Anna
    Fowlkes, Natalie
    Overman, Michael J.
    Menter, David G.
    Kopetz, Scott
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] DRUG SCREENING OF AVAILABLE ANTI-CANCER DRUGS ON PATIENT-DERIVED GBM CULTURES IDENTIFIES CANDIDATE TREATMENTS FOR A SUBPOPULATION OF GBM PATIENTS
    Ntafoulis, I.
    Kers, T.
    van der Kaaij, M.
    Balvers, R.
    Hayes, J.
    van Rij, J.
    Tching, R.
    Lindner, A.
    Prehn, J.
    Kremer, A.
    Dirven, C.
    Leenstra, S.
    Lamfers, M.
    NEURO-ONCOLOGY, 2019, 21 : 48 - 48
1234